Danco Laboratories Appeals US Court Decision on Abortion Pill Access

Danco Laboratories has filed an emergency appeal with the US Supreme Court to reverse a decision requiring in-person exams for prescribing the abortion pill mifepristone. This appeal follows a ruling by the fifth US circuit court of appeals that reinstated the requirement, impacting telemedicine providers in Louisiana.

Read the full story at The Guardian AU→